Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 
 

Capital Market Day 2015

Ready for 2016
  • Expects to deliver planned synergies from Sigma-Aldrich integration
  • Targeted investments in the pharma pipeline planned
"In the healthcare business, we are preparing specifically for growth, in Life Science the focus is on the Sigma integration and the associated cost synergies. In Performance Materials, we want to strengthen our technological leadership further and further expand our OLED business." — CEO-elect Stefan Oschmann.
 

Meet our Management

CEO Karl-Ludwig Kley, CEO-elect Stefan Oschmann and CFO Marcus Kuhnert presented an overview of the latest developments and future plans for our company through a video webcast, followed by a conference call for the media by Kley as well as Oschmann. Please find all presentations of the day for download below.

ANALYST WEBCAST

Analyst Webcast
The analyst webcast

PRESS KIT

Press Kit
The zip file contains presentations, photos and more information.

Presentations

KARL-LUDWIG KLEY

Presentation of Karl-Ludwig Kley
Presentation of Karl-Ludwig Kley

STEFAN OSCHMANN

Presentation of Stefan Oschmann
Presentation of Stefan Oschmann

MARCUS KUHNERT

Presentation of Marcus Kuhnert
Presentation of Marcus Kuhnert

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

CONTACT

Markus Talanow
MARKUS TALANOW
Financial Communications / Performance Materials
Tel: +49 6151 72-7144
Fax: +49 6151 72-3138
Merck KGaA, Darmstadt, Germany on Facebook
Merck KGaA, Darmstadt, Germany on LinkedIn
Twitter